付堂高
332300江西省武寧縣工業(yè)園衛(wèi)生院
根除幽門螺桿菌感染在治療慢性胃炎伴消化不良中的作用
付堂高
332300江西省武寧縣工業(yè)園衛(wèi)生院
doi∶10.3969/j.issn.1007-614x.2015.32.4
目的:探討根除幽門螺桿菌感染在治療慢性胃炎伴消化不良中的作用。方法:收治慢性胃炎伴消化不良患者100例,隨機(jī)分成觀察組和對(duì)照組各50例,對(duì)照組給予奧美拉唑口服,觀察組在對(duì)照組的基礎(chǔ)上加用克拉霉素和阿莫西林,比較兩組的治療效果。結(jié)果:觀察組總有效率98.0%,明顯高于對(duì)照組的74.0%(P<0.05),觀察組HP根除率100.0%,明顯高于對(duì)照組的4.0%(P<0.05)。結(jié)論:根除幽門螺桿菌感染方案治療慢性胃炎伴消化不良的臨床療效顯著。
根除;幽門螺桿菌;慢性胃炎;消化不良
慢性胃炎伴消化不良是消化內(nèi)科的常見病、多發(fā)病。目前研究證實(shí)幽門螺桿菌(HP)是導(dǎo)致慢性胃炎(Chronic gastritis)的重要因素之一[1],因此,根除幽門螺桿菌感染是治療慢性胃炎伴消化不良的關(guān)鍵。為探討根除幽門螺桿菌感染在治療慢性胃炎伴消化不良中的作用,2012年2月-2015年3月收治慢性胃炎伴消化不良患者100例,現(xiàn)報(bào)告如下。性率70.0%,患者主要表現(xiàn)為噯氣、反酸、腹痛、腹脹,兩組患者比較,差異無(wú)統(tǒng)計(jì)學(xué)意義。
方法:對(duì)照組給予奧美拉唑口服,20mg/次,2次/d,連續(xù)治療7 d。觀察組在對(duì)照組的基礎(chǔ)上加用克拉霉素,500 mg/次,2次/d,阿莫西林,1000mg/次,2次/d,連續(xù)治療7 d。
2012年2月-2015年3月收治慢性胃炎伴消化不良患者100例,隨機(jī)分成觀察組和對(duì)照組各50例,其中觀察組男20例,女30例,年齡33~75歲,平均47.5歲,HP陽(yáng)性35例,陽(yáng)性率70.0%。患者主要表現(xiàn)為噯氣、反酸、腹痛、腹脹等。對(duì)照組男21例,女29例,年齡33~77歲,平均47.7歲,HP陽(yáng)性35例,陽(yáng)
兩組患者經(jīng)過治療后臨床療效比較:觀察組總有效率98.0%,對(duì)照組總有效率74.0%,兩組比較,差異有統(tǒng)計(jì)學(xué)意義(P<0.05),見表1。
表1 兩組患者經(jīng)過治療后臨床療效比較[n(%)]
HP根除效果比較:觀察組HP陽(yáng)性35例,經(jīng)過治療全部轉(zhuǎn)陰,HP根除率100.0%;對(duì)照組HP陽(yáng)性35例,經(jīng)過治療,HP根除14例,HP根除率4.0%。兩組比較,差異有統(tǒng)計(jì)學(xué)意義(P<0.05),見表2。
消化不良是臨床常見癥狀[2],表現(xiàn)為上腹部不適、疼痛和上腹脹,常在餐后加重,并伴有食欲不振、惡心或嘔吐等。按病因劃分,消化不良可分為器質(zhì)性消化不良和功能性消化不良[3],前者經(jīng)有關(guān)檢查能顯示相關(guān)病因。幽門螺桿菌相關(guān)性胃炎是其病因之一。國(guó)內(nèi)外研究顯示:長(zhǎng)期HP感染可使胃和脊髓中P物質(zhì)、血管活性腸肽和降鈣素基因相關(guān)肽顯著增加,這些神經(jīng)肽的增加與疼痛產(chǎn)生、胃排空延緩、近端胃受限擴(kuò)張不良密切相關(guān)。根除HP感染可使胃黏膜炎癥消退,使部分消化不良患者的癥狀得到長(zhǎng)期改善[4]。
奧美拉唑用于胃腺壁細(xì)胞,為H+-K+-ATP酶抑制劑[5],選擇性地對(duì)胃酸分泌起到明顯抑制作用,起效迅速,能特異性地抑制壁細(xì)胞頂端膜構(gòu)成的分泌性胃管和胞質(zhì)內(nèi)的管狀泡上的H+-K+-ATP酶,從而有效地抑制胃酸的分泌。
表2 HP根除效果比較[n(%)]
本組資料結(jié)果顯示:觀察組總有效率98.0%,對(duì)照組總有效率74.0%,兩組比較,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。觀察組HP陽(yáng)性35例,經(jīng)過治療全部轉(zhuǎn)陰,HP根除率100.0%,對(duì)照組HP陽(yáng)性35例,經(jīng)過治療,HP根除14例,HP根除率4.0%,兩組比較,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。由此可見,根除幽門螺桿菌感染方案治療慢性胃炎伴消化不良的臨床療效顯著,值得推廣。
[1]劉文忠.幽門螺桿菌感染與非潰瘍性消化不良[J].現(xiàn)代消化及介入治療,2013,15(2)∶94-95.
[2]Tovey FI,Hobsley M,Holton J.Helicobacter pylori virulence factors in duodenal ulceration∶a primary cause or secondary infection causing chronicity[J].World JGastroenterol, 2012,12(1)∶6-9.
[3]Paulssen EJ,Lindsetmo RO.Long-term outcome of endoluminal gastroplicationin the treatment of gastro-oesophageal reflux disease effect of asecond procedure[J].Scand J Gastroenterol,2012,43(1)∶5-12.
[4]Paulssen EJ,Lindsetmo RO.Longterm outcome of endoluminal gastroplicationin the treatment of gastrooesophageal reflux disease effect of asecond procedure[J].Scand J Gastroenterol,2012,43(1)∶5-12.
[5]Masaoka T,Suzukl H,Kurubayashi K,et al. Could frameshiftmutations in the frxA and rdxA genes of Helicobacter pylori be a marker or metronidazole resistance[J].AlimentPharmacol Ther,2011,2(1)∶81-87.
Effectoferadication ofhelicobacter pyloriinfection in the treatmentof chronic gastritis com plicated with dyspepsia
Fu Tanggao
The Industrial Park Health CenterofWuning County,JiangxiProvince 332300
Objective∶To explore the effect of eradication of helicobacter pylori infection in the treatment of chronic gastritis complicated with dyspepsia.Methods∶100 patients with chronic gastritis complicated with dyspepsia were selected,they were random ly divided into the observation group and the control group with 50 cases in each,the control group was given oral omeprazole,the observation group was treated with clarithromycin and amoxicillin on the basis of the control group,we compared the therapeutic effectof two groups.Results∶The totaleffective rate of98.0%in the observation group was significantly higher than 74.0%in the control group(P<0.05),the HP eradication rate of 100.0%in the observation group was significantly higher than 4.0%of the controlgroup(P<0.05).Conclusion∶The effectoferadication ofhelicobacter pyloriinfection in the treatmentof chronic gastritiscomplicated with dyspepsiawas significant.
Eradicate;Helicobacter pylori;Chronic gastritis;Dyspepsia